Patients Stopping Weight-Loss Jabs Put On Weight Four Times Faster Compared to Those on Conventional Diets

A recent study suggests that patients who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover lost weight far faster than those who halt conventional diet and exercise plans.

Published data in a prominent health publication shows that while overweight individuals can lose substantial amounts of their total mass while using the jabs, the weight returns at an estimated rate of nearly a kilo each month after stopping.

"People using these drugs must be aware of the risk of fast weight regain when the therapy is stopped," stated lead investigator Dr. Susan Jebb.

Such speed of recovery suggests a return to original weight in about one and a half years.

Weighing Treatments

The analysis, which reviewed 37 of studies involving thousands of participants, compared the results of the injectable medications with other pills.

Researchers emphasize that individuals who shed pounds through dieting generally see a slower weight regain—approximately 100 grams monthly—after stopping.

Understanding the Quick Rebound

Nutrition scientists propose the mechanism of the drugs explains the amplified weight return.

These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Artificially providing the hormone levels far above than the body's typical production might result in the system to produce less of its endogenous hormone, and may also lessen responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this medication results in appetite is uncontrolled, making excessive eating much more probable."

A Lifelong Condition?

Health authorities suggest the injections for individuals with obesity-related health risks, accompanied by recommended lifestyle changes.

Professionals say that, considering the high risk of relapse, the treatment might need to be long-term.

This perspective is reinforced by drug manufacturers, who say that the findings "underscore the persistent character of excess weight," akin to managing conditions like diabetes.

User Accounts

Users who have come off the medication report a sudden resurgence of hunger.

"It felt as if a switch activating and you're instantly ravenous," described an individual.

The struggle is exacerbated if users have not developed permanent dietary or behavioural changes during therapy.

Widespread Use

Recent estimates show that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.

• Use is greater among females than males.
• The middle-aged age group shows the highest level of interest.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

Ultimately, researchers emphasize that while the jabs are powerful tools for shedding pounds, they are not a magic fix and maintained weight loss hinges on ongoing lifestyle support.